NeuroMetrix Reports Recent Media Coverage for Quell
NeuroMetrix, Inc. (NASDAQ:NURO) today reported continued strong media attention focusing on the company's innovative
Quell® Wearable Pain Relief Technology™. Highlights include:
Recent press coverage has reached an estimated audience of over 100MM people and included overwhelmingly positive reviews from
chronic pain sufferers who tried Quell. Blogger Jennifer Kilgore, of Wear, Tear and Care summarized her experience by
writing, "The Quell pain relief device means I can live more of my life."
"We are excited that Quell continues to attract the attention of high profile media outlets,” said Frank McGillin, Senior
Vice President and General Manager, Consumer. "The positive reviews in leading chronic pain blogs, reinforces the positive impact
that Quell is making for people dealing with chronic pain."
About Quell Wearable Pain Relief Technology
Quell is an easy-to-use, over-the-counter device for relief of chronic pain. This wearable device
utilizes NeuroMetrix's patented technology to provide widespread pain relief. In a recent clinical study, Quell improved
chronic pain in 81% of participants. Quell is currently available through select healthcare professionals, retailers and online
at www.QuellRelief.com.
About NeuroMetrix
NeuroMetrix is an innovative healthcare company that develops wearable medical technology and point-of-care tests that help
patients and physicians better manage chronic pain, nerve diseases, and sleep disorders. The company is located in Waltham,
Massachusetts and was founded as a spinoff from the Harvard-MIT Division of Health Sciences and Technology in 1996.
For more information, please visit www.NeuroMetrix.com.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20160728006410r1&sid=mstr1&distro=nx&lang=en)
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
Neurometrix.ir@neurometrix.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160728006410/en/